Key factors in cell cryopreservation and impact on manufacturability of cell and gene therapies

Cell & Gene Therapy Insights 2022; 8(3), 433;


Published: 12 April 2022
Robert Newman, PhD

Watch the video or read the poster to understand:

  • What are the key factors in cell cryopreservation, and why?
  • The principles of cell cryopreservation as learned from immune cells and stem cells
  • The importance of slow freezing of cryopreservation reagents, and related protocols for cell and gene therapy applications   
  • The critical role that source materials play in quality of the final product

Robert Newman, PhD as the Chief Scientific Officer for FUJIFILM Irvine Scientific, Robert Newman leads scientific strategy, drives global product development, and expands R&D capability for the company. He was previously Senior Director for R&D at ATCC and R&D Manager Stem Cells at BD, and holds a PhD in Biochemistry and Molecular Biology from Georgetown University.